(Q42026990)

15 October 2017

title

Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study (English)

1 reference

15 October 2017

1 reference

S A McNeill

1

1 reference

15 October 2017

T B Hargreave

series ordinal

2

1 reference

15 October 2017

Claus G Roehrborn

series ordinal

3

1 reference

15 October 2017

Alfaur study group

series ordinal

4

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

15 October 2017

1 reference

15 October 2017

volume

65

1 reference

15 October 2017

issue

1

1 reference

15 October 2017

page(s)

83-9; discussion 89-90

1 reference

Natural history of prostatism: risk factors for acute urinary retention

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Acute urinary retention in men: an age old problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

The management of men with acute urinary retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Trial without catheter following acute retention of urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Significance of acute urinary retention due to intravesical obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Symptoms and signs predictive of the voiding pattern after acute urinary retention in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

A prospective study of conservatively managed acute urinary retention: prostate size matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Long-term aspects of medical treatment of BPH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.042

10.1016/J.UROLOGY.2004.07.042

7 January 2021

Identifiers

DOI

1 reference

15 October 2017

1 reference